These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 18832877)
1. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. Clifford GM; Rickenbach M; Polesel J; Dal Maso L; Steffen I; Ledergerber B; Rauch A; Probst-Hensch NM; Bouchardy C; Levi F; Franceschi S; AIDS; 2008 Oct; 22(16):2135-41. PubMed ID: 18832877 [TBL] [Abstract][Full Text] [Related]
2. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis. Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759 [TBL] [Abstract][Full Text] [Related]
3. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414 [TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. Ayoola EA; Gadour MO J Gastroenterol Hepatol; 2004 Jun; 19(6):665-9. PubMed ID: 15151622 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. Yu MW; Yeh SH; Chen PJ; Liaw YF; Lin CL; Liu CJ; Shih WL; Kao JH; Chen DS; Chen CJ J Natl Cancer Inst; 2005 Feb; 97(4):265-72. PubMed ID: 15713961 [TBL] [Abstract][Full Text] [Related]
6. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection. Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669 [TBL] [Abstract][Full Text] [Related]
7. SEN virus infection and the risk of hepatocellular carcinoma: a case-control study. Tangkijvanich P; Theamboonlers A; Sriponthong M; Kullavanijaya P; Poovorawan Y Am J Gastroenterol; 2003 Nov; 98(11):2500-4. PubMed ID: 14638355 [TBL] [Abstract][Full Text] [Related]
8. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
9. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study. Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774 [TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital. Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414 [TBL] [Abstract][Full Text] [Related]
13. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Yu MW; Hsieh HH; Pan WH; Yang CS; CHen CJ Cancer Res; 1995 Mar; 55(6):1301-5. PubMed ID: 7882326 [TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [TBL] [Abstract][Full Text] [Related]
15. Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: a nested case-control study in Japan. Suruki RY; Mueller N; Hayashi K; Harn D; DeGruttola V; Raker CA; Tsubouchi H; Stuver SO Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2521-5. PubMed ID: 17164379 [TBL] [Abstract][Full Text] [Related]
16. High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma. Chan HL; Tse CH; Mo F; Koh J; Wong VW; Wong GL; Lam Chan S; Yeo W; Sung JJ; Mok TS J Clin Oncol; 2008 Jan; 26(2):177-82. PubMed ID: 18182659 [TBL] [Abstract][Full Text] [Related]
17. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma. Hann HW; Lee J; Bussard A; Liu C; Jin YR; Guha K; Clayton MM; Ardlie K; Pellini MJ; Feitelson MA Cancer Res; 2004 Oct; 64(20):7329-35. PubMed ID: 15492253 [TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia. Melendez-Morales L; Konkle BA; Preiss L; Zhang M; Mathew P; Eyster ME; Goedert JJ AIDS; 2007 Jul; 21(12):1631-6. PubMed ID: 17630559 [TBL] [Abstract][Full Text] [Related]
19. Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Chou YC; Yu MW; Wu CF; Yang SY; Lin CL; Liu CJ; Shih WL; Chen PJ; Liaw YF; Chen CJ Gut; 2008 Jan; 57(1):91-7. PubMed ID: 17502344 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma. Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]